cathepsin K
CTSKproteinCathepsin K is a macrophage lysosomal protease elevated in atherosclerosis, contributing to fibrous-cap matrix degradation.
Pathway placement
Cascade stepFibrous-cap degradation & rupture
Confidencemedium
RationaleLysosomal protease in macrophages; elevated in atherosclerosis; ECM degradation.
Also acts inVascular inflammation
Druggability
DruggableYes
Known drugs / candidates3
Small-molecule tractableYes
Antibody tractableYes
EnsemblENSG00000143387
Type I vs Type II discrimination
ScoresLow-confidence (proxy)
R — rupture / Type-I32
C — confounder / Type-II60
A — assay feasibility72
E — evidence strength23
T1DI (composite)6
Specificity differential (R−C)-28.6
Confounder panel (Type-II drivers)
No confounder evidence retrieved.
Tier: light (literature co-occurrence proxy — lower confidence). See the discrimination table for all markers.
Assay & specimen
Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Serum or plasma
Collection tube
Serum separator (gold/red-top, SST) · K2/K3-EDTA (lavender-top)
Method / principle
Sandwich immunoassay (ELISA) — research-grade unless a cleared assay exists
Reagent / substrate
Matched anti-target antibody pair (capture + labeled detection)
Platform
ELISA microplate or multiplex (Luminex/MSD)
Turnaround · availability
Send-out / research · Research-grade (no universal clinical assay)
Literature evidence(1)
- Endothelial dysfunction, arterial stiffening, and intima-media thickening in large arteries from HIV-1 transgenic mice.Annals of biomedical engineering · 2012 · PMID 23180031 · doi